Cross-linked Small Polyethylenimines: While Still Nontoxic, Deliver DNA Efficiently to Mammalian Cells in Vitro and in Vivo
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Polyethylenimine (PEI) is among the most efficient nonviral gene delivery vectors. Its efficiency and cytotoxicity depend on molecular weight, with the 25-kDa PEI being most efficient but cytotoxic. Smaller PEIs are noncytotoxic but less efficient. Enhancement in gene delivery efficiency with minimal cytotoxicity by cross-linking of small PEIs via potentially biodegradable linkages was explored herein. The hypothesis was that cross-linking would raise the polycation’s effective molecular weight and hence the transfection efficiency, while biodegradable linkages would undergo the intracellular breakdown after DNA delivery and hence not lead to cytotoxicity. Toward this goal, we carried out cross-linking of branched 2-kDa PEI and its 1:1 (w/w) mixture with a linear 423-Da PEI via ester- and/or amide-bearing linkages; the in vitro and in vivo gene delivery efficiency, as well as toxicity to mammalian cells, of the resultant cross-linked polycations were investigated.
The efficiency of the cross-linked PEIs in delivering in vitro a plasmid containing β-galactosidase gene and their cytotoxicity were investigated in monkey kidney cells (COS-7). Dynamic light scattering was used to compare the relative DNA condensation efficiency of the unmodified and cross-linked PEIs. In vivo gene delivery efficiency was evaluated by intratracheal delivery in mice of the complexes of a luciferase-encoding plasmid and the PEIs and estimating the luciferase expression in the lungs.
Cross-linking boosted the gene delivery efficiency of the small PEIs by 40- to 550-fold in vitro; the efficiency of the most potent conjugates even exceeded by an order of magnitude that of the branched 25-kDa PEI. Effective condensation of DNA was evident from the fact that the mean diameter of the complexes of the cross-linked PEIs was some 300 nm with a narrow size distribution, while the complexes of the unmodified small PEIs exhibited a mean size of >700 nm with a very broad size distribution. At concentrations where the 25-kDa PEI resulted in >95% cell death, the conjugates afforded nearly full cell viability. The cross-linked PEIs were 17 to 80 times m ore efficient than the unmodified ones in vivo; furthermore, their efficiencies were up to twice that of the 25-kDa PEI.
Cross-linking of small PEIs with judiciously designed amide- and ester-bearing linkers boosts their gene delivery efficiency both in vitro and in vivo without increasing the cytotoxicity. The high efficiency is dependent on the nature of the linkages and the PEIs used.
- 1. L. M. Schwiebert. Cystic fibrosis, gene therapy, and lung inflammation: for better or worse? Am. J. Physiol. 286:L715–L716 (2004).
- 2. H. S. Kingdon and R. L. Lundblad. An adventure in biotechnology: the development of haemophilia A therapeutics - from whole-blood transfusion to recombinant DNA to gene therapy. Biotechnol. Appl. Biochem. 35:141–148 (2002).
- 3. C. J. Kuo, F. Farnebo, E. Y. Yu, R. Christofferson, R. A. Swearingen, R. Carter, H. A. von Recum, J. Yuan, J. Kamihara, E. Flynn, R. D’Amato, J. Folkman, and R. C. Mulligan. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc. Natl. Acad. Sci. USA 98:4605–4610 (2001).
- 4. C.-H. Lecellier and O. Voinnet. RNA silencing: no mercy for viruses? Immunol. Revs. 198:285–303 (2004).
- 5. A. J. Frater, S. J. Fidler, and M. O. McClure. Gene therapy for AIDS and other infectious diseases. Gene Ther. 9:189–213 (2002).
- 6. Q. Ge, L. Filip, A. Bai, N. Tam, H. N. Eisen, and J. Chen. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc. Natl. Acad. Sci. USA 101:8676–8681 (2004).
- 7. Gene therapy clinical trials worldwide provided by the Journal of Gene Medicine. http://www.wiley.co.uk/genmed/clinical/.
- 8. M. E. Davis. Non-viral gene delivery systems. Curr. Opin. Biotechnol. 13:128–131 (2002).
- 9. M. Thomas and A. M. Klibanov. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 62:27–34 (2003).
- 10. C. M. Wiethoff and R. C. Middaugh. Barriers to nonviral gene delivery. J. Pharm. Sci. 92:203–217 (2003).
- 11. E. Check. Gene therapy: a tragic setback. Nature 420:116–118 (2002).
- 12. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Siqaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302:415–419 (2003). CrossRef
- 13. N. Boyce. Trial halted after gene shows up in semen. Nature 414:677–678 (2001).
- 14. G. Y. Wu and C. H. Wu. Receptor-mediated gene delivery and expression in vivo. J. Biol. Chem. 263:14621–14624 (1988).
- 15. O. Boussif, F. Lezoualc’h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J.-P. Behr. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92:7297–7301 (1995).
- 16. W. T. Godbey, K. K. Wu, and A. G. Mikos. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA 96:5177–5181 (1999).
- 17. M. Thomas and A. M. Klibanov. Enhancing polyethylenimine’s delivery of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 99:14640–14645 (2002).
- 18. J. Suh, D. Wirtz, and J. Hanes. Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. USA 100:3878–3882 (2003).
- 19. N. D. Sonawane, F. C. Szoka Jr., and A. S. Verkman. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J. Biol. Chem. 278:44826–44831 (2003).
- 20. E. Wagner. Strategies to improve DNA polyplexes for in vivo gene transfer: will “artificial viruses” be the answer? Pharm. Res. 21:8–14 (2004).
- 21. A. Kirchler. Gene transfer with modified polyethylenimines. J. Gene Med. 6:S3–S10 (2004).
- 22. M. L. Forrest, G. E. Meister, J. T. Koerber, and D. W. Pack. Partial acetylation of polyethylenimine enhances in vitro gene delivery. Pharm. Res. 21:365–371 (2004).
- 23. Y.-B. Lim, S.-M. Kim, H. Suh, and J.-S. Park. Biodegradable, endosome disruptive, and cationic network-type polymer as a highly efficient and non-toxic gene delivery carrier. Bioconjug. Chem. 13:952–957 (2002).
- 24. A. Akinc, D. M. Lynn, D. G. Anderson, and R. Langer. Parallel synthesis and characterization of a degradable polymer library for gene delivery. J. Am. Chem. Soc. 125:5316–5323 (2003).
- 25. A. Kichler, C. Leborgne, J. Marz, O. Danos, and B. Bechinger. Histidine-rich amphipathic peptide antibiotics promote efficient delivery of DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 100:1564–1568 (2003).
- 26. Y. Liu, L. Wenning, M. Linch, and T. M. Reineke. New poly(D-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. J. Am. Chem. Soc. 126:7422–7423 (2004).
- 27. S.-O. Han, R. I. Mahato, and S. W. Kim. Water-soluble lipopolymer for gene delivery. Bioconjug. Chem. 12:337–345 (2001).
- 28. S. Kim, J. S. Choi, H. S. Jang, H. Suh, and J. Park. Hydrophobic modification of polyethyleneimine for gene transfectants. Bull. Korean Chem. Soc 22:1069–1075 (2001).
- 29. C. L. Gebhart, S. Sriadibhatla, S. Vinogradov, P. Lemieux, V. Alakhov, and A. V. Kabanov. Design and formulation of polyplexes based on pluronic-polyethylenimine conjugates for gene transfer. Bioconjug. Chem. 13:937–944 (2002).
- 30. N. Oku, Y. Yamazaki, M. Matsuura, M. Sugiyama, M. Hasegawa, and M. Nango. A novel non-viral gene transfer system, polycation liposomes. Adv. Drug Deliv. Revs. 52:209–218 (2001).
- 31. M. A. Gosselin, W. Guo, and R. J. Lee. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12:989–994 (2001).
- 32. H. Petersen, K. Kunath, A. L. Martin, S. Stolnik, C. J. Roberts, M. C. Davies, and T. Kissel. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 3:926–936 (2002).
- 33. M. Thomas and A. M. Klibanov. Conjugation to gold nanoparticles enhances polyethylenimine’s transfer of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 100:9138–9143 (2003).
- 34. J. Panyam and V. Labhasetwar. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55:329–347 (2003).
- 35. J. Wang, H.-Q. Mao, and K. W. Leong. A novel biodegradable gene carrier based on polyphosphoester. J. Am. Chem. Soc. 123:9480–9481 (2001).
- 36. H. Peterson, T. Merdan, K. Kunath, D. Fisher, and T. Kissel. Poly(ethylenimine-co-L-lactamide-co-succinimide): a biodegradable polyethylenimine derivative with an advantageous pH-dependent hydrolytic degradation for gene delivery. Bioconjug. Chem. 13:812–821 (2002).
- 37. C.-H. Ahn, S. Y. Chae, Y. H. Bae, and S. W. Kim. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J. Control. Rel. 80:273–282 (2002).
- 38. Y.-B. Lim, S.-O. Han, H.-U. Kong, Y. Lee, J.-S. Park, B. Jeong, and S. W. Kim. Biodegradable polyester, poly[(α-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm. Res. 17:811–816 (2000).
- 39. Y.-B. Lim, Y. H. Choi, and J.-S. Park. A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-L-proline ester). J. Am. Chem. Soc. 121:5633–5639 (1999).
- 40. M. L. Forrest, J. T. Koerber, and D. W. Pack. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjug. Chem. 14:934–940 (2003).
- 41. A. von Harpe, H. Petersen, Y. Li, and T. Kissel. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J. Control. Rel. 69:309–322 (2000).
- 42. Y. Tan and L. Huang. Overcoming the inflammatory toxicity of cationic gene vectors. J. Drug Target 10:153–160 (2002).
- 43. D. V. Schaffer, N. A. Fidelman, N. Dan, and D. A. Lauffenburger. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol. Bioeng. 67:598–606 (2000).
- 44. C. Moon, Y. Oh, and J. A. Roth. Current status of gene therapy for lung cancer and head and neck cancer. Clin. Cancer Res. 9:5055–5067 (2003).
- 45. A. C. Willis and X. Chen. The promise and obstacle of p53 as a cancer therapeutic agent. Curr. Mol. Med. 2:329–345 (2002).
- 46. Y. Zhang, T. Li, L. Fu, C. Yu, Y. Li, X. Xu, Y. Wang, H. Ning, S. Zhang, W. Chen, L. A. Babiuk, and Z. Chang. Silencing SARS-CoV spike protein expression in cultured cells by RNA interference. FEBS Lett. 560:141–146 (2004).
- 47. D. J. Weiss. Delivery of gene transfer vectors to lung: obstacles and the role of adjunct techniques for airway administration. Mol. Ther. 6:148–152 (2002).
- Cross-linked Small Polyethylenimines: While Still Nontoxic, Deliver DNA Efficiently to Mammalian Cells in Vitro and in Vivo
Volume 22, Issue 3 , pp 373-380
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- in vitro gene delivery
- in vivo gene delivery
- plasmid DNA
- Industry Sectors
- Author Affiliations
- 1. Department of Chemistry and Division of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, USA
- 2. Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, 02139, USA